Depression And Anxiety In Cardiovascular Diseases: Emerging Role Of Psychotherapy
|
|
Author:
|
, RAJA D, ELMUTAZ BELAH MOHAMMED, MANJU ROSY JOSE, LIZ MATHEW, JAYAKUMAR C, ANAND VIJAYAKUMAR P R
|
Abstract:
|
Psychotherapy, traditionally known as ‘talking cure’ is a vital and emerging intervention that uses various techniques to reduce psychological symptoms. These symptoms can cause impaired physical, physiological, cognitive, and social functioning which in-turn leads to major adverse cardiac events. The Cardiovascular diseases (CVDs) account for about 31% of deaths globally and psychological illnesses such as depression and anxiety associated with CVDs pose a major threat to the world. Psychotherapy has proven its efficacy in helping patients change their self-destructive or unhealthy behaviors originating from negative thoughts about the disease. This review discusses the bidirectional relationship between depression and anxiety with CVDs, in addition to the role of psychotherapy in reducing depression and anxiety associated with CVDs such as Heart Failure (HF), Atrial Fibrillation (AFib) and Coronory Artery Disease (CAD) outcomes. Unrecognized, untreated depression and anxiety in cardiovascular diseases results in worsening of cardiac function and quality of life. There are also many challenges associated with antidepressants and anti-anxiety drugs in cardiovascular diseases. Therefore, appropriate screening and implementing psychological intervention helps to identify patients at risk and enhance cardiac outcomes and quality of life with limited cardiovascular side effects. However, collaborative cardiological and psychological studies are needed for providing individualized psychotherapy for CVDs patients.
|
Keyword:
|
Psychotherapy, Cardiovascular diseases, Depression, Anxiety, Cardiovascular disease
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.064
|
Download:
|
Request For Article
|
|
|